Aplasmomycin

Aplasmomycin

Aplasmomycin is an antibiotic that is derived from the Streptomyces species of bacteria. It is known for its potent antibacterial and antifungal properties.

History

Aplasmomycin was first isolated in the 1970s from a strain of Streptomyces griseus. The discovery of this antibiotic was a significant milestone in the field of pharmacology, as it offered a new tool in the fight against bacterial and fungal infections.

Structure and Properties

The structure of aplasmomycin is characterized by a unique macrolide core, which is responsible for its antibacterial and antifungal activity. This core is composed of a 16-membered lactone ring, which is decorated with various sugar moieties. The presence of these sugars is believed to enhance the drug's solubility and bioavailability.

Mechanism of Action

Aplasmomycin exerts its antibacterial and antifungal effects by inhibiting protein synthesis. It achieves this by binding to the ribosome, the cellular machinery responsible for protein production. By blocking the ribosome, aplasmomycin prevents the synthesis of essential proteins, leading to the death of the bacterial or fungal cell.

Clinical Use

Despite its potent antibacterial and antifungal properties, aplasmomycin is not commonly used in clinical practice. This is primarily due to its high toxicity, which can lead to serious side effects. However, research is ongoing to develop safer and more effective derivatives of aplasmomycin.

See Also

• Antibiotics
• Streptomyces
• Protein synthesis
• Ribosome

References

This article is a stub. You can help WikiMD by registering to expand it. Editing is available only to registered and verified users. WikiMD is a comprehensive, free health & wellness encyclopedia.